Rheumnow Podcast
EULAR 2024 SLE Topic Panel
Jun 24, 2024
Rheumatology specialists Drs. Cush, Yusof, and Fava discuss cutting-edge lupus therapies at EULAR 2024 conference. Topics include steroid reduction strategies, B-cell targeting meds, and promising results of ionolumab for cell depletion. They delve into Lupus treatment trials, advances in lupus nephritis therapies, biomarkers for disease activity prediction, and the dynamic nature of lupus nephritis.
46:42
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Gradual steroid tapering reduces lupus flare rates post-remission.
- Compound CAR T cells exhibit high effectiveness in refractory lupus nephritis.
Deep dives
Low Dose Steroid Use in Lupus
A study presented at ULR 2024 discussed the effectiveness of lower doses of steroids in lupus treatment. The study focused on achieving remission while maintaining prednisolone doses below 5 milligrams per day. Results showed that after meeting the remission criteria, patients who tapered steroids safely and gradually had lower flare rates compared to those who remained on low doses.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
